Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMA201 |
Trade Name | |
Synonyms | IMA 201|IMA- 201 |
Drug Descriptions |
IMA201 are engineered autologous T cells expressing a T-cell receptor specific to a cancer-germline peptide, which may lead to targeted anti-tumor activity (Journal of Clinical Oncology 36, no. 5_suppl). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C146779 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + IMA201 | Aldesleukin IMA201 | 0 | 1 |
IMA201 | IMA201 | 0 | 0 |